Endurant Capital Management LP Sarepta Therapeutics, Inc. Transaction History

Endurant Capital Management LP

$0
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $2.1 Million - $3 Million	-33,191 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $2.57 Million - $3.3 Million	33,191 New	33,191 $2.99 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $1.89 Million - $2.65 Million	-28,625 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $1.99 Million - $2.48 Million	28,625 New	28,625 $2.23 Million
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $2.05 Million - $4.79 Million	-28,378 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $3.56 Million - $5.07 Million	28,378 New	28,378 $4.84 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $3.28 Million - $5.24 Million	-39,822 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $3.05 Million - $5.4 Million	39,822 New	39,822 $5.14 Million
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $273,255 - $588,883	-3,753 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $1.19 Million - $1.61 Million	-10,611 Reduced 73.87%	3,753 $570,000
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $773,464 - $1.1 Million	-7,251 Reduced 33.55%	14,364 $1.71 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $1.28 Million - $1.96 Million	13,159 Added 155.62%	21,615 $2.36 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $200,870 - $281,350	1,742 Added 25.95%	8,456 $1.37 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $481,662 - $1.03 Million	6,714 New	6,714 $887,000
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $2.64 Million - $4.01 Million	-48,800 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $881,340 - $1.05 Million	-18,500 Reduced 27.49%	48,800 $2.72 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $2.4 Million - $3.17 Million	67,300	67,300 $3.05 Million

Others Institutions Holding SRPT

# of Institutions

524

Shares Held

85.2M

Call Options Held

1.74M

Put Options Held

1.39M

Black Rock Inc. New York, NY

10.3M
Shares

$1.13 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

9.09M
Shares

$996 Million
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$687 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$478 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$468 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.6B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Account